Nonalcoholic Fatty Liver Disease SIG Clinical Management of NASH in 2020

Product not yet rated

Recorded On: 11/13/2020

This symposium will focus on clinical management of NAFLD/NASH in 2020, at a time when the first NASH therapy is likely to be approved soon. Talks will explore whom to treat, how to identify these patients, current treatment options and the future of NASH diagnostics and therapy. The session includes a debate: Do we target NASH resolution or fibrosis improvement?

Key:

Complete
Failed
Available
Locked
Nonalcoholic Fatty Liver Disease SIG Clinical Management of NASH in 2020
Open to view video.
Open to view video.
You must register to access.
Final Evaluation
Final Evaluation
7 Questions
7 Questions
You must register to access.